KalVista Pharmaceuticals (KALV) Other Gross PP&E Adjustments (2017 - 2024)
KalVista Pharmaceuticals' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$9.5 million for Q4 2024.
- For Q4 2024, Other Gross PP&E Adjustments changed N/A year-over-year to -$9.5 million; the TTM value through Apr 2025 reached -$499000.0, up 83.49%, while the annual FY2024 figure was -$3.0 million, N/A changed from the prior year.
- Other Gross PP&E Adjustments for Q4 2024 was -$9.5 million at KalVista Pharmaceuticals, up from -$9.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.6 million in Q2 2020 and bottomed at -$9.8 million in Q4 2024.
- The 4-year median for Other Gross PP&E Adjustments is -$5.7 million (2024), against an average of -$5.3 million.
- The largest YoY upside for Other Gross PP&E Adjustments was 14.97% in 2020 against a maximum downside of 1881.4% in 2020.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$1.7 million in 2020, then dropped by 11.02% to -$1.9 million in 2021, then tumbled by 373.95% to -$9.0 million in 2023, then decreased by 5.25% to -$9.5 million in 2024.
- Per Business Quant, the three most recent readings for KALV's Other Gross PP&E Adjustments are -$9.5 million (Q4 2024), -$9.8 million (Q4 2024), and -$9.4 million (Q3 2024).